-
1
-
-
33646152532
-
Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: Results from a sentinel physician pilot project in British Columbia, 2004-2005
-
Accessed 3 November 2013
-
Skowronski DM, Gilbert M, Tweed SA, et al. Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005. Can Commun Dis Rep 2005; 31:181-91. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr- rmtc/05vol31/dr3118a-eng.php. Accessed 3 November 2013.
-
(2005)
Can Commun Dis Rep
, vol.31
, pp. 181-191
-
-
Skowronski, D.M.1
Gilbert, M.2
Tweed, S.A.3
-
2
-
-
33947131140
-
Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005-2006 season of dual A and B vaccine mismatch in Canada
-
Skowronski DM, Masaro C, Kwindt TL, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007; 25:2842-51.
-
(2007)
Vaccine
, vol.25
, pp. 2842-2851
-
-
Skowronski, D.M.1
Masaro, C.2
Kwindt, T.L.3
-
3
-
-
58849165403
-
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007
-
Skowronski DM, De Serres G, Dickinson J, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009; 199:168-79.
-
(2009)
J Infect Dis
, vol.199
, pp. 168-179
-
-
Skowronski, D.M.1
De Serres, G.2
Dickinson, J.3
-
4
-
-
84861563523
-
Estimates of influenza vaccine effectiveness for 2007-08 from Canada's sentinel surveillance system: Cross-protection against major and minor variants
-
Janjua NZ, Skowronski DM, De Serres G, et al. Estimates of influenza vaccine effectiveness for 2007-08 from Canada's sentinel surveillance system: Cross-protection against major and minor variants. J Infect Dis 2012; 205:1858-68.
-
(2012)
J Infect Dis
, vol.205
, pp. 1858-1868
-
-
Janjua, N.Z.1
Skowronski, D.M.2
De Serres, G.3
-
5
-
-
77951745708
-
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: Four observational studies from Canada
-
Skowronski DM, De Serres G, Crowcroft NS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during spring-summer 2009: four observational studies from Canada. PLoS Med 2010; 7:e1000258.
-
(2010)
PLoS Med
, vol.7
-
-
Skowronski, D.M.1
De Serres, G.2
Crowcroft, N.S.3
-
6
-
-
79952060021
-
Effectiveness of AS03- adjuvanted pandemic H1N1 vaccine: Case-control evaluation based on sentinel surveillance system in Canada, autumn 2009
-
Skowronski DM, Janjua NZ, De Serres G, et al. Effectiveness of AS03- adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. Br Med J 2011; 342:c7297.
-
(2011)
Br Med J
, vol.342
-
-
Skowronski, D.M.1
Janjua, N.Z.2
De Serres, G.3
-
7
-
-
84863973361
-
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-11 season
-
Skowronski DM, Janjua NZ, De Serres G, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-11 season. Clin Infect Dis 2012; 55:332-42.
-
(2012)
Clin Infect Dis
, vol.55
, pp. 332-342
-
-
Skowronski, D.M.1
Janjua, N.Z.2
De Serres, G.3
-
8
-
-
84856769572
-
Statement on seasonal influenza vaccine for 2011-2012
-
National Advisory Committee on Immunization (NACI) Accessed 3 November 2013
-
National Advisory Committee on Immunization (NACI). Statement on seasonal influenza vaccine for 2011-2012. Can Commun Disease Rep 2011; 37:1-55. Available at: http://www.phac-aspc.gc.ca/publicat/ccdrrmtc/11vol37/acs-dcc-5/ index-eng.php. Accessed 3 November 2013.
-
(2011)
Can Commun Disease Rep
, vol.37
, pp. 1-55
-
-
-
10
-
-
79959716834
-
Serologic assays for influenza surveillance, diagnosis and vaccine evaluation
-
Katz JM, Hancock K, Xu X. Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev Anti Infect Ther 2011; 9:669-83.
-
(2011)
Expert Rev Anti Infect Ther
, vol.9
, pp. 669-683
-
-
Katz, J.M.1
Hancock, K.2
Xu, X.3
-
11
-
-
84879209428
-
-
August. Accessed 3 November 2013
-
World Health Organization. WHOinformation for molecular diagnosis of influenza virus in humans - update. August 2011. Available at: http://www.who.int/influenza/resources/documents/molecular-diagnosis-influenza- virus-humans-update-201108.pdf. Accessed 3 November 2013.
-
(2011)
WHOinformation for Molecular Diagnosis of Influenza Virus in Humans - Update
-
-
-
12
-
-
84155162558
-
Efficacy and effectiveness of influenza vaccines: A systematic review and metaanalysis
-
Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and metaanalysis. Lancet Infect Dis 2012; 12:36-44.
-
(2012)
Lancet Infect Dis
, vol.12
, pp. 36-44
-
-
Osterholm, M.T.1
Kelley, N.S.2
Sommer, A.3
Belongia, E.A.4
-
13
-
-
84859086467
-
Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012
-
pii=20129. Accessed 3 November 2013
-
Jimenez-Jorge S, de Mateo S, Pozo F, et al. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill 2012; 17:pii=20129 (p 1-6). Available at: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20129. Accessed 3 November 2013.
-
(2012)
Euro Surveill
, vol.17
, pp. 1-6
-
-
Jimenez-Jorge, S.1
De Mateo, S.2
Pozo, F.3
-
14
-
-
84892775673
-
Influenza vaccine effectiveness in the 2011-2012 season: Protection against each circulating virus and the effect of prior vaccination on estimates
-
Ohmit SE, Thompson MG, Petrie JG, et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014; 58:319-27.
-
(2014)
Clin Infect Dis
, vol.58
, pp. 319-327
-
-
Ohmit, S.E.1
Thompson, M.G.2
Petrie, J.G.3
-
15
-
-
84862874157
-
I-MOVE case-control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: Results from the I-MOVE multicentre case-control study 2011/12
-
pii=20146. Accessed 3 November 2013
-
Kissling E, Valenciano M, I-MOVE case-control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12. Euro Surveill 2012; 17:pii=20146 (p 1-7). Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20146. Accessed 3 November 2013.
-
(2012)
Euro Surveill
, vol.17
, pp. 1-7
-
-
Kissling, E.1
Valenciano, M.2
-
16
-
-
84873314436
-
Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: Results from the I-MOVE multicentre case-control study
-
pii=20390. Accessed 3 November 2013
-
Kissling E, Valenciano M, Larrauri A, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill 2013; 18:pii=20390 (p 1-10). Available at: http://www.eurosurveillance. org/ViewArticle.aspx?ArticleId=20390. Accessed 3 November 2013.
-
(2013)
Euro Surveill
, vol.18
, pp. 1-10
-
-
Kissling, E.1
Valenciano, M.2
Larrauri, A.3
-
17
-
-
84873314743
-
Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratoryconfirmed influenza in primary care in the United Kingdom: Evidence of waning intra-seasonal protection
-
pii=20389. Accessed 3 November 2013
-
Pebody RG, Andrews N, McMenamin J, et al. Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratoryconfirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection . Euro Surveill 2013; 18:pii=20389 (p 1-8). Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20389. Accessed 3 November 2013.
-
(2013)
Euro Surveill
, vol.18
, pp. 1-8
-
-
Pebody, R.G.1
Andrews, N.2
McMenamin, J.3
-
18
-
-
84874618250
-
Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine- mismatched influenza B/yamagata-lineage viruses in Taiwan, 2011-12 season
-
Accessed 3 November 2013
-
Lo Y-C, Chuang J-H, Kuo H-W, et al. Surveillance and Vaccine Effectiveness of an Influenza Epidemic Predominated by Vaccine- Mismatched Influenza B/Yamagata-Lineage Viruses in Taiwan, 2011-12 Season. PLoS One 2013; 8:e58222. Available at: http://www.plosone.org/article/info%3Adoi%2F10. 1371%2Fjournal.pone.0058222. Accessed 3 November 2013.
-
(2013)
PLoS One
, vol.8
-
-
Lo, Y.-C.1
Chuang, J.-H.2
Kuo, H.-W.3
-
19
-
-
84888024210
-
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution
-
Koel BF, Burke DF, Bestebroer TM, et al. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 2013; 342:976-79.
-
(2013)
Science
, vol.342
, pp. 976-979
-
-
Koel, B.F.1
Burke, D.F.2
Bestebroer, T.M.3
-
20
-
-
84873306270
-
Statement on seasonal influenza vaccine for 2012-2013
-
National Advisory Committee on Immunization (NACI) Accessed 3 November 2013
-
National Advisory Committee on Immunization (NACI). Statement on seasonal influenza vaccine for 2012-2013. Can Commun Disease Report 2012; 38:1-36. Available at: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/12vol38/acs-dcc-2/ index-eng.php. Accessed 3 November 2013.
-
(2012)
Can Commun Disease Report
, vol.38
, pp. 1-36
-
-
-
21
-
-
0036924361
-
Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons
-
ShawMW, Xu X, Li Y, et al. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology 2002; 303:1-8.
-
(2002)
Virology
, vol.303
, pp. 1-8
-
-
Shaw, M.W.1
Xu, X.2
Li, Y.3
-
23
-
-
77958553266
-
Clinical efficacy of cell-culture derived and egg-derived inactivated subunit influenza vaccines in healthy adults
-
Frey S, Vesikari T, Szymczakiewicz-Multanowska A, et al. Clinical efficacy of cell-culture derived and egg-derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis 2010; 51:997-1004.
-
(2010)
Clin Infect Dis
, vol.51
, pp. 997-1004
-
-
Frey, S.1
Vesikari, T.2
Szymczakiewicz-Multanowska, A.3
-
24
-
-
84879212793
-
Comparing influenza vaccine efficacy against mismatched and matched strains: A systematic review and meta-analysis
-
Accessed 3 November 2013
-
Tricco AC, Chit A, Soobiah C, et al. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Med 2013; 11:153. Available at: http://www.biomedcentral.com/1741-7015/11/ 153. Accessed 3 November 2013.
-
(2013)
BMC Med
, vol.11
, pp. 153
-
-
Tricco, A.C.1
Chit, A.2
Soobiah, C.3
-
25
-
-
80052925426
-
Influenza B/Victoria antigen induces strong recall of B/Yamagata but lower B/Victoria response in children primed with two doses of B/Yamagata
-
Skowronski DM, Hottes TS, De Serres G, et al. Influenza B/Victoria antigen induces strong recall of B/Yamagata but lower B/Victoria response in children primed with two doses of B/Yamagata. Ped Infect Dis J 2011; 30:833-9.
-
(2011)
Ped Infect Dis J
, vol.30
, pp. 833-839
-
-
Skowronski, D.M.1
Hottes, T.S.2
De Serres, G.3
-
26
-
-
84856270981
-
Antibody persistence and response to 2010-11 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children
-
Epub 2011 Nov 7
-
Gilca V, De Serres G, Hamelin M-E, et al. Antibody persistence and response to 2010-11 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children. Vaccine 2011; 30:35-41. Epub 2011 Nov 7.
-
(2011)
Vaccine
, vol.30
, pp. 35-41
-
-
Gilca, V.1
De Serres, G.2
Hamelin, M.-E.3
-
27
-
-
84893309583
-
Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: A population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons
-
Thompson MG, Li DK, Shifflett P, et al. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis 2014; 58:449-457.
-
(2014)
Clin Infect Dis
, vol.58
, pp. 449-457
-
-
Thompson, M.G.1
Li, D.K.2
Shifflett, P.3
-
28
-
-
84862690493
-
Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: Immunologic interactions and B/Yamagata dominance
-
Skowronski DM, Hamelin M-E, Janjua NZ, et al. Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance. PLoS One 2012; 7:e38929.
-
(2012)
PLoS One
, vol.7
-
-
Skowronski, D.M.1
Hamelin, M.-E.2
Janjua, N.Z.3
-
29
-
-
84872224039
-
Persistence of influenza vaccine-induced antibody in lung transplant patients and healthy individuals beyond the season
-
Severson JJ, Richards KR, Moran JJ, Hayney MS. Persistence of influenza vaccine-induced antibody in lung transplant patients and healthy individuals beyond the season. Hum Vaccin Immunother 2012; 8:1850-3.
-
(2012)
Hum Vaccin Immunother
, vol.8
, pp. 1850-1853
-
-
Severson, J.J.1
Richards, K.R.2
Moran, J.J.3
Hayney, M.S.4
-
30
-
-
0022658480
-
Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine
-
Clements ML, Murphy BR. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol 1986; 23:66-72.
-
(1986)
J Clin Microbiol
, vol.23
, pp. 66-72
-
-
Clements, M.L.1
Murphy, B.R.2
-
31
-
-
40049108737
-
Rapid decline of influenza vaccine-induced antibody in the elderly: Is it real, or is it relevant?
-
Skowronski DM, Tweed SA, De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant? J Infect Dis 2008; 197:490-502.
-
(2008)
J Infect Dis
, vol.197
, pp. 490-502
-
-
Skowronski, D.M.1
Tweed, S.A.2
De Serres, G.3
-
32
-
-
84871049662
-
Kinetics of the antibody response to seasonal influenza vaccination among the elderly
-
Kositanont U, Assantachai P, Puthavathana P, Praditsuwan R. Kinetics of the antibody response to seasonal influenza vaccination among the elderly. Viral Immuno 2012; 25:471-6.
-
(2012)
Viral Immuno
, vol.25
, pp. 471-476
-
-
Kositanont, U.1
Assantachai, P.2
Puthavathana, P.3
Praditsuwan, R.4
-
33
-
-
84877257252
-
Influenza vaccine effectiveness in the community and the household
-
Ohmit SE, Petrie JG, Malosh RE, et al. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis 2013; 56: 1363-69.
-
(2013)
Clin Infect Dis
, vol.56
, pp. 1363-1369
-
-
Ohmit, S.E.1
Petrie, J.G.2
Malosh, R.E.3
-
34
-
-
84880380404
-
Understanding suboptimal influenza vaccine effectiveness within the agent, host, and environment paradigm
-
Skowronski DM, Janjua NZ, De Serres G. Understanding suboptimal influenza vaccine effectiveness within the agent, host, and environment paradigm. Clin Infect Dis 2013; 57:476-7.
-
(2013)
Clin Infect Dis
, vol.57
, pp. 476-477
-
-
Skowronski, D.M.1
Janjua, N.Z.2
De Serres, G.3
-
35
-
-
84880366281
-
Stratified estimates of influenza vaccine effectiveness by prior vaccination: Caution required
-
Sullivan SG, Kelly H. Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required. Clin Infect Dis 2013; 57:474-6.
-
(2013)
Clin Infect Dis
, vol.57
, pp. 474-476
-
-
Sullivan, S.G.1
Kelly, H.2
-
36
-
-
0033601790
-
Protection against influenza after annually repeated vaccination: A metaanalysis of serologic and field studies
-
Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD. Protection against influenza after annually repeated vaccination: a metaanalysis of serologic and field studies. Arch Intern Med 1999; 159:182-8.
-
(1999)
Arch Intern Med
, vol.159
, pp. 182-188
-
-
Beyer, W.E.1
De Bruijn, I.A.2
Palache, A.M.3
Westendorp, R.G.4
Osterhaus, A.D.5
-
37
-
-
0030849623
-
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period
-
Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 1997; 15:1114-22.
-
(1997)
Vaccine
, vol.15
, pp. 1114-1122
-
-
Keitel, W.A.1
Cate, T.R.2
Couch, R.B.3
Huggins, L.L.4
Hess, K.R.5
-
39
-
-
70350574121
-
Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort
-
Irving SA, Donahue JG, Shay DK, Ellis-Coyle TL, Belongia EA. Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort. Vaccine 2009; 27:6546-9.
-
(2009)
Vaccine
, vol.27
, pp. 6546-6549
-
-
Irving, S.A.1
Donahue, J.G.2
Shay, D.K.3
Ellis-Coyle, T.L.4
Belongia, E.A.5
-
40
-
-
84899793877
-
-
Accessed 3 November 2013
-
Statistics Canada. Table 105-0502 - Health indicator profile, two year period estimates, by age group and sex, Canada, provinces, territories, health regions (2012 boundaries) and peer groups, occasional, CANSIM (database). Available at: http://www.statcan.gc.ca/tables-tableaux/sumsom/l01/cst01/ health102b-eng.htm. Accessed 3 November 2013.
-
Table 105-0502 - Health Indicator Profile, Two Year Period Estimates, by Age Group and Sex, Canada, Provinces, Territories, Health Regions (2012 Boundaries) and Peer Groups, Occasional, CANSIM (Database)
-
-
-
41
-
-
79952257810
-
H1N1 vaccination
-
Catalogue no. 82-003-XPE. Accessed 3 November 2013
-
Gilmour H, Hofmann N. H1N1 vaccination. Health Reports 2010 21(4). Statistics Canada, Catalogue no. 82-003-XPE. Available at: http://www.statcan. gc.ca/pub/82-003-x/2010004/article/11348-eng.pdf. Accessed 3 November 2013.
-
(2010)
Health Reports
, vol.21
, Issue.4
-
-
Gilmour, H.1
Hofmann, N.2
-
42
-
-
34547843673
-
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness
-
Orenstein EW, De Serres G, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007; 36:623-31.
-
(2007)
Int J Epidemiol
, vol.36
, pp. 623-631
-
-
Orenstein, E.W.1
De Serres, G.2
Haber, M.J.3
-
43
-
-
84884215211
-
The test-negative design: Validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomized double-blind placebocontrolled trials
-
pii: 20585. Accessed 7 December 2013
-
De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomized double-blind placebocontrolled trials. Euro Surveillance 2013; 18. pii:20585 (p 1-9). Available at: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20585. Accessed 7 December 2013.
-
(2013)
Euro Surveillance
, vol.18
, pp. 1-9
-
-
De Serres, G.1
Skowronski, D.M.2
Wu, X.W.3
Ambrose, C.S.4
-
44
-
-
51249116765
-
Population patterns of chronic health conditions, comorbidity and healthcare use in Canada: Implications for policy and practice
-
Broemeling AM,Watson DE, Prebtani F. Population patterns of chronic health conditions, comorbidity and healthcare use in Canada: implications for policy and practice. Healthcare Quarterly 2008; 11:70-6.
-
(2008)
Healthcare Quarterly
, vol.11
, pp. 70-76
-
-
Broemeling, A.M.1
Watson, D.E.2
Prebtani, F.3
|